- Home
- NVAX
NVAX
Novavax Inc.
as 11-22-2024 4:00pm EST
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | GAITHERSBURG |
| Market Cap: | 2.0B | IPO Year: | 1995 |
| Target Price: | $17.83 | AVG Volume (30 days): | 5.8M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.99 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.53 - $23.86 | Next Earning Date: | 11-12-2024 |
| Revenue: | $885,193,000 | Revenue Growth: | -15.68% |
| Revenue Growth (this year): | -21.04% | Revenue Growth (next year): | -28.30% |
Latest Novavax Inc. News
NVAX Breaking Stock News: Dive into NVAX Ticker-Specific Updates for Smart Investing
Barrons.com
3 days ago
Matt Gaetz Withdraws. Why That Might Be Bad News for RFK.
MT Newswires
6 days ago
B. Riley Adjusts Novavax Price Target to $22 From $26, Maintains Buy Rating
Zacks
6 days ago
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Investor's Business Daily
9 days ago
Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS
Investor's Business Daily
9 days ago
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?
MT Newswires
9 days ago
Update: Moderna, Novavax, Pfizer Shares Fall on Nomination of Anti-Vaxxer as US Health Secretary
Yahoo Finance Video
9 days ago
Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
Investor's Business Daily
9 days ago
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
Compare NVAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NVAX Novavax Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.